Gabor Illés

Proxenia Venture Partners LLC (Proxenia Venture Partners) is a venture capital firm founded in 2016 by Menghis Bairu. The firm is headquartered in wilmington, Delaware.

Marex Group Plc provides brokerage services for commodities, financials, and foreign exchange. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments. The Clearing segment allows the clients access to exchanges and clearing houses. The Agency and Execution segment match buyers and sellers on an agency basis by facilitating price discovery of commodities and financial markets. The Market Making segment offers direct market pricing to professional and wholesale counterparties in a variety of commodity and securities markets. The company was founded by Mark Slade in 2005 and is headquartered in London, the United Kingdom.

eMMUNITY, Inc. operates as a diagnostic and immunotherapy development company. It targets cancer therapy and prevention for genetically related cancer patients. The company was founded by Julianna Lisziewicz in 2013 and si headquartered in Bethesda, MD.

Genetic Immunity LLC develops nanomedicines for immune amplification. It offers an immunetherapy platform technology that includes a plasmid DNA based antigen, a nanomedicine formulation, and a topical administration device that targets antigens to dendritic cells. The company was founded by Julianna Lisziewicz and is headquartered in McLean, VA.

Central European Petroleum Ltd. operates as a petroleum exploration and production company. It pursues exploration and production projects in Middle Europe with focus on Germany. The firm also holds leases in Mecklenburg-Vorpommern and Brandenburg. The company was founded by Peter E. Putnam and Alula Damte in 2006 and is headquartered in Calgary, Canada.

Shred-it International, Inc. provides shredding services. Its services include scheduled paper shredding, hard drive destruction, on-demand shredding, media destruction, drop off shredding and specialty shredding. The company was founded by Greg Brophy in 1988 and is headquartered in Oakville, Canada.

Croesus Holdings Ltd is a British company led by the management of Croesus Financial Services Ltd.

Crossroads Capital Investments, Inc. (Crossroads Capital) is a private equity firm founded in 2000. the firm headquartered in Road Town, British Virgin Islands.

Ceské Radiokomunikace AS provides television, radio and internet broadcasting solutions. It offers backbone network, transmitting infrastructure, access technologies, internet connection, data solutions for corporate and wholesale customers. The company was founded in 1963 and is headquartered in Prague, Czech Republic.

Part of UBS Group AG, Credit Suisse First Boston (Budapest) Rt. The company is based in Budapest, Hungary. is a Hungarian company that provides investment advice.

Ostravsko Karvinske Doly as mines, processes, and sells hard coal with low content of sulfur or other matters. It products are used as fuel and in coke production in chemical industry and other sectors. The company is headquartered in Karviná, Czech Republic.

New World Resources NV produces coke and hard coal. Its products include thermal coal, coking coal and coal catalogue. The company was founded on December 29, 2005 and is headquartered in London, the United Kingdom.

Renaissance Capital CJSC is a company based in Moscow, Russian Federation. and has subsidiaries in Kazakhstan and Kenya. The Russian company was founded by Stephen Jennings, Boris Alexis Jordan, Peter Kadas.

Food Freshness Technology Holdings Ltd. manufactures and distributes filters. The company is headquartered in Cranfield, the United Kingdom.

Speranza Therapeutics, Inc. distributes and clinically supports innovative drugs and medical devices requiring FDA approval or clearance. Speranza Therapeutics is based in Boca Raton, FL, and the CEO of the private company is Sal J. Rafanelli. The company targets patients whose chronic illnesses and debilitating conditions are not being effectively addressed. The company offers a non-invasive treatment called S.T. Genesis to manage opioid withdrawal symptoms. This FDA-cleared medical device reduces the physical and emotional strain of withdrawal experienced by those suffering.

Part of Prothena Corp. Plc, Prothena Therapeutics Ltd. is an Irish nonprofit company located in Dublin that provides business services.

NewBridge Pharmaceuticals FZ LLC engages in the manufacture and distribution of pharmaceutical products, therapeutics and medical devices. The company was founded by G. Garrett Vygantas in 2007 and is headquartered in Dubai, United Arab Emirates.

Bairex Medical is a company based in San Francisco, CA.

Serenus Biotherapeutics, Inc. distributes and manufactures pharmaceutical drug products. The company is headquartered in San Francisco, CA.

A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA.

Fremont Health Corp. provides healthcare services. It specializes in the areas of cancer care, diabetes care, business health and maternity care. The company was founded in 1940 and is headquartered in Fremont, NE.

Cognni Ltd. is an AI-powered information security company based in Tel Aviv, Israel. Cognni offers a unique solution for the information security field, providing organizations with human-like understanding of their most critical information assets. The Israeli company's autonomous mapping feature saves infosec teams hundreds of hours by automating tasks associated with minimizing insider risks, configuring information security, and mitigating ransomware damages. Cognni is a member of the prestigious Microsoft Intelligent Security Association and is focused on providing unparalleled transparency in its quest to redefine compliance and data governance with human-like intelligence. The company was founded in 2017 by Amichai Marueli and Guy Eisdorfer, with Guy Eisdorfer serving as the CEO since then.

Pizza Union Ltd. is an Italian pizza bar that specializes in fire-baked Roman style thin and crispy 12" pizzas. The private company was founded in 2012 and is based in London, UK. The British company offers superfast service all day.

BlueTree Technologies Ltd. is a foodtech company based in Kiryat Shmona, Israel. BlueTree's proprietary technology and system physically and selectively reduces sugar content (up to 50%%) from 100%% squeezed natural orange juice, making it natural, healthy, and tasty. The Israeli company's technology and system offer several significant benefits to the natural juice industry, including reduced sugar, improved blending properties, and improved reduced storage and distribution. BlueTree is the first "graduate" of the FreshStart Food Tech Incubator, partnered by Tnuva, Tempo, OurCrowd, and Finistere Ventures, and is one of the leading players in the thriving northern food tech ecosystem. The company was founded by Yuval Klein and Didier Toubia, and Michael Gordon has been the CEO of the company since 2022.

Fibronostics US, Inc. operates healthcare technology company, which develops algorithms to detect disease and monitor progression. The firm provides platform that develops non-invasive algorithm based diagnostics to improve treatment outcomes, facilitate screening of specific diseases and help prognosis in various chronic conditions. The company was founded in 2015 and is headquartered in Orlando, FL.

Phoska Biopharma Pte Ltd. develops advancing new therapies for treating liver and metabolic conditions. The company is headquartered in Singapore.

Virostatics Srl is a privately held small pharmaceutical company based in Sassari, Italy. The Italian company is dedicated to discovering and developing novel compounds for the treatment of cancers and viral diseases. The company focuses on novel, selective, host cell kinase targeted inhibitors and inherently hindering the oncogene myc. The team and advisors combine scientific, business, legal, and technology expertise, spanning from translational science through preclinical and clinical drug development. Virostatics has developed a bioaerosol system to test nebulized drug treatments, inhalers, disinfectants, or devices for virucidal activity in a state-of-the-art biosafety level 3 facility. The company has developed a robust pipeline of proprietary compounds to distinguish themselves from the competition through their unique kinase selectivity, efficacy, and safety profiles. The company was founded by Franco Lori, who has been the CEO since incorporation.